SCANDURRA, GIUSEPPA
 Distribuzione geografica
Continente #
AS - Asia 398
EU - Europa 368
NA - Nord America 269
SA - Sud America 105
AF - Africa 8
OC - Oceania 1
Totale 1.149
Nazione #
US - Stati Uniti d'America 253
HK - Hong Kong 184
SG - Singapore 166
IE - Irlanda 151
BR - Brasile 95
IT - Italia 56
DE - Germania 45
FR - Francia 35
GB - Regno Unito 24
TR - Turchia 19
FI - Finlandia 15
AT - Austria 11
CA - Canada 8
BD - Bangladesh 6
MX - Messico 6
CZ - Repubblica Ceca 4
JP - Giappone 4
MA - Marocco 4
NL - Olanda 4
AR - Argentina 3
BO - Bolivia 3
CH - Svizzera 3
IN - India 3
PL - Polonia 3
RU - Federazione Russa 3
SE - Svezia 3
UA - Ucraina 3
CN - Cina 2
KG - Kirghizistan 2
LV - Lettonia 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
BE - Belgio 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
GR - Grecia 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 1.149
Città #
Hong Kong 184
Dublin 151
Singapore 65
The Dalles 57
Boardman 51
Santa Clara 24
Istanbul 16
London 14
Frankfurt am Main 13
Helsinki 12
Los Angeles 12
São Paulo 11
Munich 10
Milan 9
Assago 8
Palermo 8
Düsseldorf 6
Misilmeri 6
New York 6
Agrigento 5
Ashburn 5
Mexico City 5
Portsmouth 5
Belo Horizonte 4
Brno 4
Lauterbourg 4
Nuremberg 4
Seattle 4
Atlanta 3
San Francisco 3
Stockholm 3
Varallo Pombia 3
Warsaw 3
Zurich 3
Campinas 2
Catania 2
Caxias do Sul 2
Dhaka 2
Fortaleza 2
Jeddah 2
La Paz 2
Montreal 2
Osaka 2
Riga 2
Rio de Janeiro 2
Rome 2
Roubaix 2
Secaucus 2
Suzano 2
Tokyo 2
Tremestieri Etneo 2
Triggiano 2
Turku 2
Vienna 2
Volta Redonda 2
West Jordan 2
Alegrete 1
Amman 1
Amparo 1
Amsterdam 1
Ankara 1
Anshan 1
Aparecida de Goiânia 1
Ariquemes 1
Athens 1
Auckland 1
Augusta 1
Bacabal 1
Baghdad 1
Baku 1
Bananal 1
Bangkok 1
Barreiras 1
Birmingham 1
Bishkek 1
Boston 1
Brasília 1
Brooklyn 1
Brussels 1
Buffalo 1
Cabo Frio 1
Cabo de Santo Agostinho 1
Campo Grande 1
Canoas 1
Cape Town 1
Carneiros 1
Caruaru 1
Catalão 1
Cerquilho 1
Cerro Azul 1
Chandigarh 1
Charlotte 1
Chennai 1
Chicago 1
Chittagong 1
Ciudad Benito Juárez 1
Colombo 1
Comodoro Rivadavia 1
Cosmópolis 1
Criciúma 1
Totale 809
Nome #
Efficacy and safety of neoadjuvant paclitaxel, ifosfamide, and cisplatin (TIP) chemotherapy in locally advanced squamous cell cervical carcinoma followed by radical surgery: A single institution experience 52
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 50
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 42
Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma 42
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer 39
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 34
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 31
The long survival in oncology: which QoL? Finding study in more than five years after the end of treatment 30
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report 29
Syringoid eccrine carcinoma of the vulva: differential diagnosis, treatment, and follow-up 29
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay 29
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy 28
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 27
The group's waiting room: groups of self-help in oncology 26
Brain Metastasis in Endometrial Cancer: A Systematic Review 25
Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report 25
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 24
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 24
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy 21
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 20
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 19
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study 19
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 19
Appropriate Management of Cutaneous Adverse Events Maximizes Compliance with Sorafenib Treatment: A Single-Center Experience 18
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status 18
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 18
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 18
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study 17
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 17
Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications 17
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 17
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 16
Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 15
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? 15
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 15
Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 14
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 14
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 14
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer ( ROC) patients with BRCA 1/2 mutation. A monoistitutional experience 14
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 14
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study 14
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 14
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity 13
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice 13
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 13
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma 13
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort 13
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis 13
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 13
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 13
Unveiling the Intricate Dance: How Cancer Orchestrates Muscle Wasting and Sarcopenia 12
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study. 11
Multidisciplinary team for elucidation of any new mutation and how this approach can be useful to individualize any genetic result: the case of BRCA2 c.631G>A/c.7008-2A>T genotype 10
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy 10
De-escalation of complexity in oncoplastic breast surgery: Case series from a specialized breast center 10
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention 9
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment 9
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 8
Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance 8
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 8
The importance of planning a correct therapeutic strategy in patients with recurrent ovarian cancer. 8
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 8
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 8
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial 7
Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen 7
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial 6
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 6
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 6
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study 5
Totale 1.243
Categoria #
all - tutte 8.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 0 0 0 1 0
2023/2024213 1 2 13 10 24 16 34 21 14 18 26 34
2024/20251.029 40 17 30 8 61 131 110 100 127 153 149 103
Totale 1.243